Lite Strategy, Inc. — Director's Dealing 2023

Jun 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-06-02

Reporting Person: Urso David M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-02	Stock Option (Right to Buy)	$7.5	A	166571	Acquired	2033-06-02	Common Stock (166571)	Direct

Footnotes

F1: One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.